When was Owkin founded?

Owkin was founded in 2016 and became a unicorn in 2021.

Where is Owkin located?

Owkin is headquartered in Paris, France. It is registered at Harju County, Tallinn, City Center District, Vana-Lõuna Street 39-147, 10134.

Which legal entities is Owkin associated with?

Owkin is associated with Seiland Brygge OÜ and 3 others.

How many employees does Owkin have?

As of Aug 31, 2026, the latest employee count at Owkin is 421.

Is Owkin a funded company?

Owkin is a funded company, having raised a total of $321M across 12 funding rounds to date. The company's 1st funding round was a $2.1M Seed round, raised on Nov 2016.

How much is Owkin worth?

The latest valuation of Owkin is $1B as of Nov 18, 2021.

When was the latest funding round of Owkin?

Owkin's latest funding was a $216K Grant (prize money) round on Jan 01, 2023, with participation from 1 investor. Its primary sector is Artificial Intelligence. In France, the Artificial Intelligence sector has seen $5.53B in funding in 2026 to date.

What is the annual revenue of Owkin?

Annual revenue of Owkin is between €10M and €50M as on Dec 31, 2020

Is Owkin a Artificial Intelligence company?

The primary sectors of Owkin are Artificial Intelligence, Life Sciences Tech and Agentic AI.

Where does Owkin rank among its competitors?

Owkin ranks 3rd amongst 109 active competitors, of which 23 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Qureight, which secured $20M in Jul, 2026.

Who are the top competitors of Owkin?

Owkin's top competitors include Manifold AI, Komodo Health and Reliant AI. Among them, Qureight secured the most recent funding round in July, 2026.

Owkin - 2026 Company Profile, Team, Funding, Competitors & Financials

Owkin is a series B company based in Paris (France), founded in 2016 by Gilles Wainrib. It operates as an AI generative biology company to create the new standard of biology reasoning. Owkin has raised $321M in funding from investors like Google Ventures, Otium Capital and MACSF, with a current valuation of $1B. The company has 109 active competitors, including 23 funded and 4 that have exited. Its top competitors include companies like Manifold AI, Komodo Health and Reliant AI.

Sectors and market segments that Owkin operate in

Owkin serves in the Native AI, HealthTech, Life Sciences, High Tech market segments.The primary business model of Owkin are:

Company Details

AI generative biology company to create the new standard of biology reasoning. The company is creating the only large-scale reasoning model trained natively on patient-level multimodal data and reinforced through real biological feedback — a closed-loop system that continuously improves itself. It is building the operating system for biology a platform in general-purpose biology intelligence.

Website: www.owkin.com/
Social
Email ID: *****@owkin.com
Registered Address: Harju County, Tallinn, City Center District, Vana-Lõuna Street 39-147, 10134

Key Metrics

Founded Year

2016

Location

Paris, France

Stage

Series B

Total Funding

$321M in 12 rounds

Latest Funding Round

Grant (prize money), Jan 01, 2023, $216K

Post Money Valuation

$1B as on Nov 18, 2021

Investors

Google Ventures & 19 more

Ranked

3^rd among 109 active competitors

Annual Revenue

€10M - €50M as on Dec 31, 2020

Employee Count

421 as on Aug 31, 2026

Investment & Acquisitions

Bioptimus & 1 more

Similar Companies

OpenEvidence & 2964 more

View Owkin's full profile

Owkin is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
OWKIN FRANCE CIN: 822393591 , France, Active	Mar 08, 2016	€10M - €50M (As on Dec 31, 2020)	-	-
Seiland Brygge OÜ CIN: 11834085 , Estonia, Active	Dec 23, 2009	€0 - €1M (As on Dec 31, 2022)	1 (As on Jun 30, 2024)
OWKIN UK LTD CIN: 11834085 , United Kingdom, Active	Feb 18, 2019	-	38 (As on Dec 31, 2024)
Owkin, Inc. CIN: 812819948 , United States, Active	May 26, 2016	-	17 (As on Dec 31, 2023)	-

Owkin has raised a total funding of $321M over 12 rounds. Its first funding round was on Nov 2016. Its latest funding round was a Grant (prize money) round on Jan 01, 2023 for $216K. 1 investor participated in its latest round. Owkin has 16 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Owkin:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2023	$216K	Grant (prize money)	-	-	-	Europa
Jun 08, 2022	$80M	Series B	-	-	-	Bristol-Myers Squibb
Nov 18, 2021	$180M	Series B	$1B	32.9x	-	Sanofi

Access funding benchmarks and valuations. Sign up today!

View details of Owkin's funding rounds and investors

The founders of Owkin is Gilles Wainrib.

Here are the details of Owkin's key team members:

Gilles Wainrib: Co-Founder of Owkin. They are also an angel investor in 1 startup.

Owkin's Board of Directors

Owkin's board has 1 active member. Rochereau De La Sabliere is part of team.

Here is the list of Owkin's board of directors:

Name	Type	Representing	Status	Duration
Rochereau De La Sabliere	Team	-	Current	-

View details of Owkin's Founder profiles and Board Members

Owkin's employee count trend

Owkin has 421 employees as of Aug 26. Here is Owkin's employee count trend over the years:

Uncover Owkin's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Owkin include Manifold AI, Komodo Health and Reliant AI. Here is the list of Top 10 competitors of Owkin, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Manifold AI 2016, Oakland (United States), Series B	Provider of an AI platform for life sciences research and development	$40M	TQ Ventures, Reach Capital & 13 others	72/100
2nd	Komodo Health 2014, New York City (United States), Series E	AI and cloud-based platforms provide data-driven insights to healthcare providers	$514M	Tiger Global Management, Coatue & 14 others	72/100
3rd	Owkin 2016, Paris (France), Series B	AI generative biology company to create the new standard of biology reasoning	$321M	Sanofi, Mubadala & 18 others	71/100
4th	Reliant AI 2023, Montreal (Canada), Acquired	Provider of an AI platform for biopharmaceutical research and development	$13.5M	Inovia Capital, Tola Capital & 6 others	58/100
5th	Qureight 2018, Cambridge (United Kingdom), Series B	AI enabled data curation platform for drug development	$31.2M	Molten Ventures, Playfair Capital & 21 others	57/100
6th	Seven Bridges Genomics 2009, Cambridge (United States), Acquired	Biomedical data analysis company accelerating healthcare research with software and analytics	$113M	First Star Ventures, Western Technology Investment ... & 3 others	54/100
7th	Rivia 2002, Switzerland, Series A	Provider of an AI-powered data analytics platform for clinical trials	$18.2M	Earlybird, Speedinvest & 3 others	54/100
8th	IDBS 1989, Guildford (United Kingdom), Acquired	Data management for research teams	$4.96M	Elaia	50/100
9th	Advaita Bioinformatics 2005, Plymouth (United States), Funding Raised	Provider of bioinformatics software tools focused on multi-omics pathway analysis	-	Venture for America, America’s Seed Fund & 4 others	49/100
10th	Cellbyte 2024, Munich (Germany), Seed	AI-driven analytics platform that enables pricing and market access professionals in the pharmaceutical industry	$3.25M	Frontline Ventures, Y Combinator & 3 others	49/100